8-KEarnings & ResultsExhibits & Filings

BIOGEN INC. 8-K Report, Financial Results (Feb 6, 2009)

Filed February 6, 2009For Securities:BIIB

Summary

Biogen Idec Inc. filed an 8-K report on February 6, 2009, to announce its financial results for the full year and fourth quarter ended December 31, 2008. The report primarily references a press release (Exhibit 99.1) that contains the detailed operational and financial performance data. Investors should refer to this press release for specific figures on revenue, profitability, and other key financial metrics for the period. While the 8-K itself does not contain the granular financial data, its purpose is to formally report the release of these results. The information presented in the associated press release is crucial for understanding Biogen Idec's performance and financial standing as of the end of 2008, impacting investment decisions regarding the company's trajectory and valuation.

Key Highlights

  • 1Biogen Idec announced its full-year and fourth-quarter 2008 financial results on February 6, 2009.
  • 2The company filed a Form 8-K to report these results, referencing an accompanying press release (Exhibit 99.1).
  • 3Investors can find detailed operational and financial performance information in the press release dated February 6, 2009.
  • 4The filing pertains to the period ended December 31, 2008.
  • 5This report serves as the official notification of the release of the company's year-end financial statements and performance data.
  • 6The press release is furnished and not deemed 'filed' under Section 18 of the Exchange Act, meaning liabilities under that section do not apply to the press release's content.

Frequently Asked Questions

The main purpose of this Form 8-K filing by Biogen Idec Inc. is to officially announce and report the company's financial results for the full year and the fourth quarter ended December 31, 2008. It serves as a notification to investors and the public that these results have been released.

The detailed financial results are contained within the press release dated February 6, 2009, which is furnished as Exhibit 99.1 to this 8-K filing. Investors should refer to this press release for specific financial performance data.

No, this Form 8-K filing itself does not contain the detailed financial statements. It primarily references and incorporates by reference a press release (Exhibit 99.1) that was issued by Biogen Idec on February 6, 2009, which holds the comprehensive results.

The press release not being deemed 'filed' under Section 18 of the Securities Exchange Act of 1934 means that Biogen Idec, Inc. is not subject to the specific liabilities associated with 'filed' documents under that section concerning the content of the press release. While it's furnished as part of the report, the company is afforded a degree of protection regarding the precise accuracy of statements within the press release compared to officially 'filed' documents.